{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:25:23Z","timestamp":1772011523588,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jdcr.2023.01.001","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T21:09:53Z","timestamp":1672952993000},"page":"27-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Dupilumab-induced pityriasis rosea"],"prefix":"10.1016","volume":"33","author":[{"given":"Morgan","family":"Zabel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace A.","family":"Hile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alanna","family":"Shefler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul W.","family":"Harms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May P.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer B.","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jdcr.2023.01.001_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cea.13491","article-title":"Mechanisms of dupilumab","volume":"50","author":"Harb","year":"2020","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.jdcr.2023.01.001_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40257-021-00646-z","article-title":"Dupilumab facial redness\/dupilumab facial dermatitis: a guide for clinicians","volume":"23","author":"Muzumdar","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jdcr.2023.01.001_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13142","article-title":"Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: a case series","volume":"32","author":"Napolitano","year":"2019","journal-title":"Dermatol Ther"},{"issue":"10","key":"10.1016\/j.jdcr.2023.01.001_bib4","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s40265-017-0768-3","article-title":"Dupilumab: first global approval","volume":"77","author":"Shirley","year":"2017","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.jdcr.2023.01.001_bib5","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/pde.14820","article-title":"Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children","volume":"38","author":"Parker","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jdcr.2023.01.001_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jdcr.2021.11.007","article-title":"Dupilumab-induced erythema nodosum","volume":"19","author":"Mustin","year":"2021","journal-title":"JAAD Case Rep"},{"issue":"6","key":"10.1016\/j.jdcr.2023.01.001_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15117","article-title":"Dupilumab-induced urticaria","volume":"34","author":"Mastorino","year":"2021","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.jdcr.2023.01.001_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D380D8301D","article-title":"Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center","volume":"12","author":"Atzori","year":"2006","journal-title":"Dermatol Online J"},{"issue":"6","key":"10.1016\/j.jdcr.2023.01.001_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/1346-8138.12103","article-title":"Pityriasis rosea-like drug eruption related to rituximab treatment","volume":"40","author":"Sezer","year":"2013","journal-title":"J Dermatol"},{"issue":"5 suppl 1","key":"10.1016\/j.jdcr.2023.01.001_bib10","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1016\/j.jaad.2004.10.888","article-title":"Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases","volume":"53","author":"Brazzelli","year":"2005","journal-title":"J Am Acad Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623000012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623000012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:24:53Z","timestamp":1762475093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512623000012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":10,"alternative-id":["S2352512623000012"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.01.001","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dupilumab-induced pityriasis rosea","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. This is an open access..","name":"copyright","label":"Copyright"}]}}